Cellular immunotherapy for plasma cell myeloma

Bone Marrow Transplantation

Volumn 48, Issue 11, 2013, Pages 1377-1386

  Garfall, A L ^a   Vogl, D T ^a   Weiss, B M ^a   Stadtmauer, E A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DENDRITIC CELL VACCINE; DEXAMETHASONE; DOXORUBICIN; EPITOPE; FLUDARABINE; GLYCOPROTEIN GP 130; HLA A2 ANTIGEN; IMATINIB; INFLUENZA VACCINE; IPILIMUMAB; MELANOMA ANTIGEN 3; MELPHALAN; MYCOPHENOLIC ACID; PEPTIDE VACCINE; PIDILIZUMAB; PNEUMOCOCCUS VACCINE; PROGRAMMED DEATH 1 RECEPTOR; PROTEASOME INHIBITOR; TELOMERASE; THALIDOMIDE; THIOTEPA; THYMOCYTE ANTIBODY; TRANSCRIPTION FACTOR GATA 2; TUMOR VACCINE; UNINDEXED DRUG; VINCRISTINE;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER GROWTH; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CELL EXPANSION; CELL FUSION; CLINICAL EFFECTIVENESS; DENDRITIC CELL; DRUG MEGADOSE; EX VIVO STUDY; GENETIC ENGINEERING; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; INFLUENZA; LYMPHOCYTIC INFILTRATION; METASTATIC MELANOMA; MULTIPLE MYELOMA; NONMYELOABLATIVE STEM CELL TRANSPLANTATION; OVERALL SURVIVAL; PLASMA CELL; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; REDUCED INTENSITY CONDITIONING; T LYMPHOCYTE; TUMOR IMMUNITY; WHOLE BODY RADIATION;

HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOTHERAPY, ADOPTIVE; MULTIPLE MYELOMA; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURVIVAL ANALYSIS;

EID: 84887256938     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2013.54     Document Type: Article

References (0)